Royalty Pharma vs Revolution Medicines

Royalty Pharma (RPRX), health care, and Revolution Medicines (RVMD), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Royalty Pharma is worth $39.5B on the stock market and Revolution Medicines $35.2B: Royalty Pharma is valued at 12% more. Over the past year Royalty Pharma's share price has moved +73.7% and Revolution Medicines's +136%.

Key facts

Royalty Pharma market value
$39.5B
Revolution Medicines market value
$35.2B
Royalty Pharma P/E
44.9
Royalty Pharma revenue
$2.4BFY to 2025-12-31
Revolution Medicines revenue
$0FY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Royalty Pharma vs Revolution Medicines: every measure side by side
Measure Royalty Pharma Revolution Medicines
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$39.5Bhigher$35.2Blower
Revenue$2.4Bhigher$0lower
Earnings$770.9Mhigher-$1.1Blower
Employees100lower883higher
Total assets$19.6Bhigher$2.4Blower
Valuation
P/E44.9—
P/S16.6—
P/B4.5lower14.7higher
Dividend yield1.35%higher0.00%lower
Profitability
Operating margin65.6%—
Balance sheet
Net assets$9.7Bhigher$1.6Blower
Total liabilities$9.9Bhigher$723.2Mlower
Total debt$9B—
Cash on hand$618.7Mhigher$383.7Mlower
Price change
Today+0.23%higher-2.50%lower
1 year+73.7%lower+136%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Percentages are each holding's share of that investor's reported portfolio. Who owns RPRX · Who owns RVMD

Further comparisons

Learn

Questions and answers

Which is bigger, Royalty Pharma or Revolution Medicines?

By market value, Royalty Pharma is the larger: $39.5B against $35.2B for Revolution Medicines. By revenue in its latest fiscal year, Royalty Pharma is the larger: $2.4B against $0 for Revolution Medicines.

Which has the higher dividend yield?

Royalty Pharma: 1.35%, against 0.00% for Revolution Medicines. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Royalty Pharma and Revolution Medicines?

None of the tracked superinvestors holds both in their latest 13F filing. 5 hold Royalty Pharma and 5 hold Revolution Medicines.

Cite this page

Funkfolio, “Royalty Pharma vs Revolution Medicines”, data as of 18 November 2026. https://funkfolio.com/compare/rprx-vs-rvmd

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.